Silence Therapeutics develops siRNA medicines that switch off disease-linked genes, with candidates for blood, heart and obesity conditions. It last closed at $19.80 on Nov 17, up 0.00% on the day. In the past 30 days there were 14 dark pool prints totaling $43.6M, the largest $12.1M.
Only 1 firm rated SLN in the past 90 days, not enough for a consensus
Average 12-month target
$20.00
▲ 1.0% upside
Based on 1 analyst who set a price target on SLN in the past 90 days. The average target is $20.00, with a high of $20.00 and a low of $20.00, compared with the last close of $19.80.
Low $20.00Avg $20.00High $20.00
Blue marker: last close $19.80
Highest target$20.00
Average target$20.00
Lowest target$20.00
Latest rating changes
HC Wainwright & Co.Downgrade
Oct 21Hold$75 → $20
Morgan StanleyMaintained
Aug 11Buy$32
HC Wainwright & Co.Reiterated
Jun 17Buy$75
Date
Firm
Action
Rating
Price target
Oct 21
HC Wainwright & Co.
Downgrade
Hold
$75 → $20
Aug 11
Morgan Stanley
Maintained
Buy
$32
Jun 17
HC Wainwright & Co.
Reiterated
Buy
$75
Loading…
Technical Analysis
SLN · as of the Nov 17 close · updated after every close
Uptrend, overbought
The stock is 0% above its 20 day and 25% above its 50 day average. It is 50% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 78), overbought. The nearest support is the Pivot S1 at $19.78, and the nearest resistance the swing high (Nov 3) at $19.82.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 1.8%/day
Key levels
$19.8652 week high+0.3%
$19.82Pivot R1+0.1%
$19.82Swing high (Nov 3)+0.1%
$19.80Pivot+0.0%
$19.80Last close
$19.78Pivot S1−0.1%
$19.7620 day average−0.2%
$19.70Swing low (Nov 9)−0.5%
$14.8950 day average−24.8%
$13.51100 day average−31.8%
$9.93200 day average−49.8%
$4.1952 week low−78.8%
Indicators
RSI (14)
77.68
Overbought above 70
Overbought
MACD
1.44
Below its signal line
Bearish
Stochastic
71.0
Middle of its range
Neutral
ADX (14)
57.2
Strong uptrend
Williams %R
-35.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
86.1
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.1%
Change over 10 sessions
Bullish
ATR (14)
$0.35
Typical daily range, 1.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityLow, 8.8%/day
Key levels
$19.8652 week high+0.3%
$19.82Pivot R1+0.1%
$19.82Swing high (Nov 3)+0.1%
$19.80Pivot+0.0%
$19.80Last close
$19.78Pivot S1−0.1%
$19.7620 day average−0.2%
$19.70Swing low (Nov 9)−0.5%
$14.8950 day average−24.8%
$13.51100 day average−31.8%
$9.93200 day average−49.8%
$4.1952 week low−78.8%
Indicators
RSI (14)
71.71
Overbought above 70
Overbought
MACD
2.79
Above its signal line
Bullish
Stochastic
99.3
Near the top of its range
Overbought
ADX (14)
39.2
Trending up
Williams %R
-0.5
Oversold below −80, overbought above −20
Overbought
CCI (20)
127.7
Oversold below −100, overbought above 100
Overbought
Rate of change
+52.1%
Change over 10 sessions
Bullish
ATR (14)
$1.74
Typical daily range, 8.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for SLN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow SLN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How SLN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SLN is in one of them and how their past SLN trades turned out.
Silence Therapeutics is a biotechnology company based in London that develops small interfering RNA, or siRNA, medicines. These molecules work by switching off specific genes linked to disease in the liver, which lowers the proteins those genes produce. Its candidates target rare blood disorders, heart and cholesterol conditions, and obesity. The company is also seeking outside partners to help take some of these treatments further.